# Cogent Biosciences, Inc. (COGT): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/cogt for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from advanced gastrointestinal stromal tumors (GIST). Furthermore, Cogent holds a licensing pact with Plexxikon Inc., granting it rights for the investigation, advancement, and marketing of bezuclastinib....

## Quote & Key Metrics

As of 2026-10-26:

| Metric | Value |
|---|---|
| Price | $30.73 USD |
| Market Cap | $5.33B |
| P/E (TTM) | — |
| EPS (TTM) | −$2.10 |
| 52-Week Range | $13.78 – $43.73 |
| Dividend Yield (TTM) | — |

## Dividend

COGT has no dividend payment history in our records.

## Frequently Asked Questions

### What does Cogent Biosciences, Inc. do?

Cogent Biosciences, Inc. (COGT) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is COGT's market cap?

Cogent Biosciences, Inc. (COGT) has a market capitalization of approximately $5.33 billion, as of October 26, 2026, based on the most recent share price and shares outstanding.

### Does COGT pay a dividend?

No, Cogent Biosciences, Inc. (COGT) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is COGT profitable?

Cogent Biosciences, Inc. (COGT) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has COGT ever paid a dividend?

No. Dividend Data's records show no dividend payments from Cogent Biosciences, Inc. (COGT). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/cogt
- Dividend history & safety: https://www.dividenddata.com/stocks/cogt/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/cogt/earnings
- Financial statements: https://www.dividenddata.com/stocks/cogt/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/cogt/valuation
- Peer comparison: https://www.dividenddata.com/stocks/cogt/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.